Inhibrx Biosciences Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022
Period Ending	May '25 May 16, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Market Capitalization	175	223	-	-
Enterprise Value	64	28	-	-
Last Close Price	12.02	15.40	-	-
PE Ratio	0.11	0.13	-	-
PS Ratio	870.00	1114.65	-	-
PB Ratio	1.84	1.67	-	-
P/TBV Ratio	1.84	1.67	-	-
EV/Sales Ratio	320.05	142.16	-	-
Debt / Equity Ratio	1.13	0.06	4.83	-0.69
Asset Turnover	0.00	0.00	0.01	-
Inventory Turnover	39.39	34.28	35.84	-
Quick Ratio	4.97	3.76	4.95	0.01
Current Ratio	5.12	3.94	5.25	0.30
Return on Equity (ROE)	4118.34%	1905.92%	-1333.38%	-
Return on Assets (ROA)	-107.28%	-67.38%	-84.42%	-
Return on Capital (ROIC)	-150.65%	-83.29%	-108.99%	-
Earnings Yield	990.21%	757.00%	-	-
FCF Yield	-96.98%	-88.37%	-	-
Buyback Yield / Dilution	-23.83%	-27.17%	-	-

Updated Mar 17, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q